BioCryst to Present at Upcoming Investor Conferences
RESEARCH TRIANGLE PARK, N.C., Feb. 22, 2023 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today
Globe Newswire22-02-2023, 19:04
General Fusion confirms significant fusion neutron yield and plasma stability during MTF compression experiment series with new peer-reviewed publication 23-11-2024, 02:45